Cargando…
A Case of NAA10-related Syndrome With Prolonged QTc Treated With a Subcutaneous Implantable Cardioverter Defibrillator After Ventricular Fibrillation
NAA10 is an enzyme involved in the N-terminal acetylation of proteins. NAA10-related syndrome is caused by a pathogenic variant of NAA10 on X chromosome, resulting in several phenotypes, including mental retardation, hypotonia, growth retardation, and various external malformations, with varying deg...
Autores principales: | Mizuno, Yuta, Ichikawa, Yasuhiro, Kawai, Shun, Wakamiya, Takuya, Murakami, Hiroaki, Kurosawa, Kenji, Ueda, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642139/ https://www.ncbi.nlm.nih.gov/pubmed/37969489 http://dx.doi.org/10.1016/j.cjcpc.2022.10.001 |
Ejemplares similares
-
The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014) -
Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017) -
The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022) -
Subcutaneous Implantable Cardioverter Defibrillator: Early
Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017) -
Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators
por: Liang, Jin-Jun, et al.
Publicado: (2019)